Page last updated: 2024-10-30

metformin and Muscular Dystrophies, Limb-Girdle

metformin has been researched along with Muscular Dystrophies, Limb-Girdle in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Muscular Dystrophies, Limb-Girdle: A heterogenous group of inherited muscular dystrophy that can be autosomal dominant or autosomal recessive. There are many forms (called LGMDs) involving genes encoding muscle membrane proteins such as the sarcoglycan (SARCOGLYCANS) complex that interacts with DYSTROPHIN. The disease is characterized by progressing wasting and weakness of the proximal muscles of arms and legs around the HIPS and SHOULDERS (the pelvic and shoulder girdles).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ono, H1
Suzuki, N1
Kanno, SI1
Kawahara, G1
Izumi, R1
Takahashi, T1
Kitajima, Y1
Osana, S1
Nakamura, N1
Akiyama, T1
Ikeda, K1
Shijo, T1
Mitsuzawa, S1
Nagatomi, R1
Araki, N1
Yasui, A1
Warita, H1
Hayashi, YK1
Miyake, K1
Aoki, M1

Other Studies

1 other study available for metformin and Muscular Dystrophies, Limb-Girdle

ArticleYear
AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2020, 04-08, Volume: 28, Issue:4

    Topics: AMP-Activated Protein Kinases; Animals; Cell Line; Disease Models, Animal; Dysferlin; Humans; Lasers

2020